Keywords
How to Cite
Abstract
Cardiovascular pathology is one of the frequent comorbidities in patients with chronic obstructive pulmonary disease, due to both genetic predisposition and common risk factors (smoking, senile age, male gender, sedentary lifestyle, obesity). The article shows that development of endothelial dysfunction is one of the earliest phases of pathogenesis in this setting. Endothelial dysfunction mechanisms are defined and characterized, including an imbalance of vasoconstricting and vasodilating agents with the emergence of "vicious circles" that violate hemo-vascular homeostasis. The role of nitric oxide, endothelin-1, intercellular adhesion molecule-1 (ICAM-1) in the development of endothelial dysfunction in COPD patients is discussed.
The article defines the concept of oxidative stress, the most potent oxidants and mechanisms of their damaging effect arebeing listed. A particular attention is paid to 8-isoprostane as a golden standard in assessment of oxidative stress in patients with COPD .
References
References
Lopez, A. D., Shibuya, K., Rao, C., Mathers, C. D., Hansell, A. L., Held, L. S., ... & Buist, S. (2006). Chronic obstructive pulmonary disease: current burden and future projections. European Respiratory Journal, 27(2), 397-412. doi.org/10.1183/09031936.06.00025805
Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine, 3(11), e442. doi.org/10.1371/journal.pmed.0030442
Trupin, L., Earnest, G., San Pedro, M., Balmes, J. R., Eisner, M. D., Yelin, E., ... & Blanc, P. D. (2003). The occupational burden of chronic obstructive pulmonary disease. European Respiratory Journal, 22(3), 462-469. doi.org/10.1183/09031936.03.00094203
Dahl, R., Chung, K. F., Buhl, R., Magnussen, H., Nonikov, V., Jack, D., ... & Kramer, B. (2010). Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax, 65(6), 473-479. doi.org/10.1136/thx.2009.125435
Feshhenko, Ju. I. (2009). HOZL v Ukraine: problemy i puti reshenija. Zdorov’ja Ukraїni, 9(1), 3−4 (in Russian).
Global'naja strategija diagnostiki, lechenija i profilaktiki HOBL. Peresmotr 2011 g. Per. s angl. / pod red. A.S. Belevskogo. M.: Rossijskoe respiratornoe obshhestvo, 2012. 80s. [Global Initiative for Chronic Obstructive Lung Diseases. Global Strategy for Diagnosis, Management and Prevention for Chronic Obstructive Lung Diseases (Revised 2011). Rossiyskoe Respiratornoye Obschestvo Publ., 2012 (in Russian)].
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008). Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. European Respiratory Journal, 32(4), 962-969. doi.org/10.1183/09031936.00012408
Ovcharenko, S. I. (2018). Serdechno-sosudistaja patologija u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih: kak my lechim?. RMZh, 26(10-1), 36-39 [Ovcharenko, S.I. (2018). Cardiovascular pathology in patients with chronic obstructive pulmonary disease: how do we treat it? RMJ. 10 (I), 36–39] (in Russian).
Babak, O. Ja., Shaposhnikova, Ju. N., & Nemcova, V. D. (2004). Arterial'naja gipertenzija i ishemicheskaja bolezn' serdca-jendotelial'naja disfunkcija: sovremennoe sostojanie voprosa. Ukrainskij terapevticheskij zhurnal, (1), 14-22.
Chuchalin, A. G. (2008). Hronicheskaja obstruktivnaja bolezn' legkih i soputstvujushhie zabolevanija. Pul'monologija, (2), 5-14 (in Russian).
Feary. J, & Branes N. (2009). Abstract, ERS, 19 Annual Congress. sept.13. P. 962.
Brodskaja, T. A., Nevzorova, V. A., Gelcer, B. I., & Motkina, E. V. (2007). Jendotelial'naja disfunkcija i bolezni organov dyhanija. Terapevticheskij arhiv, 79(3), 76-84 (in Russian).
Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S., & Kalayci, O. (2012). Oxidative stress and antioxidant defense. World Allergy Organization Journal, 5(1), 9-19.doi.org/10.1097/wox.0b013e3182439613
Kovaljova, O. N., Ashcheulova, T. V., Gerasimchuk, N. N., & Safargalina-Kornilo-va, N. A. (2015). Rol'oksidativnogo stressa v stanovlenii i progressirovanii gipertonicheskoj bolezni [Role of oxidative stress in the formation and progression of hypertensive disease]. Nauchnye Vedomosti Belgorodskogo Gosudarstvennogo Universiteta Medicina Farmacija, Aktual'nye problemy mediciny, 29(4(201)), 5-10 (in Russian).
Rahman, I., & Adcock, I. M. (2006). Oxidative stress and redox regulation of lung inflammation in COPD. European respiratory journal, 28(1), 219-242. doi.org/10.1183/09031936.06.00053805
Yin, H. (2008). New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo. Biofactors, 34(2), 109-124. doi.org/10.1002/biof.5520340203
Herasymchuk, N. (2018). 8-isoprostane as the main marker of oxidative stress. Zaporozhye medical journal. Volume 20. No. 6 (11), 2018, - 853-859. doi.org/10.14739/2310-1210.2018.6.146780
Horváth, I., Hunt, J., & Barnes, P. J. (2005). Exhaled breath condensate: methodological recommendations and unresolved questions.
European Respiratory Journal,26(3), 523-548. doi.org/10.1183/09031936.05.00029705
Kostikas, K., Papatheodorou, G., Psathakis, K., Panagou, P., & Loukides, S. (2003). Oxidative stress in expired breath condensate of patients with COPD. Chest, 124(4), 1373-1380. doi.org/10.1378/chest.124.4.1373
Montuschi, P., Collins, J. V., Ciabattoni, G., Lazzeri, N., Corradi, M., Kharitonov, S. A., & Barnes, P. J. (2000). Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. American journal of respiratory and critical care medicine, 162(3), 1175-1177.doi.org/10.1164/ajrccm.162.3.2001063
Antczak, A., Ciebiada, M., Pietras, T., Piotrowski, W. J., Kurmanowska, Z., & Górski, P. (2012). Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease. Archives of medical science: AMS, 8(2), 277-285. oi.org/10.5114/aoms.2012.28555
Biernacki, W. A., Kharitonov, S. A., & Barnes, P. J. (2003). Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax, 58(4), 294-298. doi.org/10.1136/thorax.58.4.294
Anaev, Je. H., Kushaeva, M. Je., & Kurova, V. S. (2012). Znachenie proteomnogo analiza kondensata vydyhaemogo vozduha pri diagnostike HOBL i pnevmonii. Pul'monologija. 5, 5–9.
Ko, F. W., Lau, C. Y., Leung, T. F., Wong, G. W., Lam, C. W., & Hui, D. S. (2006). Exhaled breath condensate levels of 8-isoprostane, growth related oncogene α and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respiratory medicine, 100(4), 630-638. doi.org/10.1016/j.rmed.2005.08.009
Wanner, A., & Mendes, E. S. (2010). Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research. American journal of respiratory and critical care medicine, 182(11), 1344-1351. doi.org/10.1164/rccm.201001-0038pp
Malaja, L. T., Korzh, A. N., & Balkovaja, L. B. (2000). Jendotelial'naja disfunkcija pri patologii serdechno-sosudistoj sistemy. Har'kov: Torsing, 432 (in Russian).
Hall C. (2001). The value of natriuretic peptides for the management of heart failure: current state of play. European Journal of Heart Failure. 3(4): 395–397. doi.org/10.1016/s1388-9842(01)00151-9
Ashheulova, T. V., Kovaleva, O. N., Gerasimchuk, N. N., & Safargalina-Kornilova, N. A. (2016). Funkcional'noe sostojanie jendotelija i aktivnost' provospalitel'nyh citokinov u bol'nyh gipertonicheskoj bolezn'ju, associirovannoj s ozhireniem [Endothelial function and activity of proinflammatory cytokines in patients with hypertension associated with obesity]. Nauchnye Vedomosti Belgorodskogo Gosudarstvennogo Universiteta Medicina Farmacija, Aktual'nye problemy mediciny, 34(12 (233)), 5-14 (in Russian).
Ribeiro, F., Alves, A. J., Teixeira, M., Ribeiro, V., Duarte, J. A., & Oliveira, J. (2009). Endothelial function and atherosclerosis: circulatory markers with clinical usefulness. Revista portuguesa de cardiologia: orgao oficial da Sociedade Portuguesa de Cardiologia= Portuguese journal of cardiology: an official journal of the Portuguese Society of Cardiology, 28(10), 1121-1151.
Lapshina, L. A., Molodan, V. I., Shevchenko, O. S., & Nemcova, V. D. (2001). Jendotelial'naja disfunkcija pri nachal'nyh stadijah arterial'noj gipertenzii i sposoby ee nemedikamentoznoj korrekcii. Ukrainskij terapevticheskij zhurnal, 3(4), 39 (in Russian).
Danilenko, S. A., & Landyshev, Ju. S. (2010). Mikrogemocirkuljatornye narushenija v slizistoj obolochke bronhov pri hronicheskoj obstruktivnoj bolezni legkih. Regionarnoe krovoobrashhenie i mikrocirkuljacija, 9(1), 38-41 (in Russian).
Van Suylen, R. J., Smits, J. F., & Daemen, M. J. (1998). Pulmonary artery remodeling differs in hypoxia-and monocrotaline-induced pulmonary hypertension. American journal of respiratory and critical care medicine, 157(5), 1423-1428 (in Russian). doi.org/10.1164/ajrccm.157.5.9709050
Bakakos, P., Patentalakis, G., & Papi, A. (2016). Vascular Biomarkers in Asthma and COPD. Curr Top Med Chem. 16(14), 1599-1609. doi.org/10.2174/1568026616666150930121157
Shao, D., Park, J. E., & Wort, S. J. (2011). The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension. Pharmacological Research, 63(6), 504-511. doi.org/10.1016/j.phrs.2011.03.003
Almagro, P., Cabrera, F. J., Diez, J., Boixeda, R., Ortiz, M. B. A., Murio, C., & Soriano, J. B. (2012). Comorbidities and Short-term Prognosis in Patients Hospitalized for Acute Exacerbation of COPDComorbidity and Prognosis in COPD Hospitalized Patients The EPOC en Servicios de Medicina Interna (ESMI) Study. Chest Journal, 142(5), 1126-1133. doi.org/10.1378/chest.11-2413
Mannino, D. M., & Sanderson, W. T. (2017). Using big data to reveal chronic respiratory disease mortality patterns and identify potential public health interventions. Jama, 318(12), 1112-1114. doi.org/10.1001/jama.2017.11746
Ives, S. J., Harris, R. A., Witman, M. A., Fjeldstad, A. S., Garten, R. S., McDaniel, J., ... & Richardson, R. S. (2014). Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension, 63(3), 459-467. doi.org/10.1161/hypertensionaha.113.02255
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003). Chronic obstructive pulmonary disease: molecular and cellularmechanisms. European Respiratory Journal, 22(4), 672-688. doi.org/10.1183/09031936.03.00040703
Makarova, M. A., Avdeev, S. N., & Chuchalin, A. G. (2014). Arterial'naja rigidnost' i jendotelial'naja disfunkcija u pacientov s hronicheskoj obstruktivnoj bolezn'ju legkih: chto pervichno? [Arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease: what is primary and secondary?] Pul'monologija, (6), 73-79 (in Russian). doi.org/10.18093/0869-0189-2011-0-6-73-79
Оеlsnеr, Е.C., Pоttingеr, T.D., Burkаrt, K.M., & Аllisоn, M. (2013). Аdhеsiоnmоlеculеs, еndоthеlin-1 аnd lung functiоni n sеvеn pоpulаtiоn-bаsеdcоhоrts. Biоmаrkеrs; 18 (3), 196–203.
Wаltеr, R.E., Wilk, J.B., Lаrsоn, M.G., & Vаsаn RS. (2008). Systеmic inflаmmаtiоn аnd CОPD: thе Frаminghаm Hеаrt Study. Chеst; 133 (1), 19–25.
Hе, Z. J. H., & Zhi, H. X. Z. (2010). Intеgrin-аssоciаtеd prоtеins in blооd plаsmа оf pаtiеnts with аcutееxаcеrbаtiоn оf chrоnic оbstructivе pulmоnаry disеаsе. Аrticlе in Chinеsе, 33(4), 265-7.
Riise, G. C., Larsson, S., Lofdahl, C. G., & Andersson, B. A. (1994). Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. European Respiratory Journal, 7(9), 1673-1677. doi.org/10.1183/09031936.94.07091673
Pollock, D. M. (2005). Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension, 45(4), 477-480.
Ashheulova, T. V., Zaika, M. V., & Gerasimchuk, N. N. (2007). Vzaimosvjaz' immunnoj aktivacii i oksidativnogo stressa pri progressirovanii arterial'noj gipertenzii. [The relationship between immune activation and oxidative stress in the progression of arterial hypertension]. Ukrainskij terapevticheskij zhurnal, 2, 12-15 (in Russian).
Barua, R. S., Ambrose, J. A., Eales-Reynolds, L. J., DeVoe, M. C., Zervas, J. G., & Saha, D. C. (2001). Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation, 104(16), 1905-1910. doi.org/10.1161/hc4101.097525
Butler, R., Morris, A. D., & Struthers, A. D. (2001). Cigarette smoking in men and vascular responsiveness. British journal of clinical pharmacology, 52(2), 145-149. doi.org/10.1046/j.0306-5251.2001.01434.x
Karoli, N. A., & Rebrov, A. P. (2004). Vlijanie kurenija na razvitie jendotelial'noj disfunkcii u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih. Pul'monologija, 2(14), 70-78.
Laurent, S., Katsahian, S., Fassot, C., Tropeano, A. I., Gautier, I., Laloux, B., & Boutouyrie, P. (2003). Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke, 34(5), 1203-1206. doi.org/10.1161/01.str.0000065428.03209.64
Mahendra, M., Kumar, S., Desai, N., Jayaraj, B. S., & Mahesh, P. A. (2018). Evaluation for airway obstruction in adult patients with stable ischemic heart disease. Indian heart journal, 70(2), 266-271. doi.org/10.1016/j.ihj.2017.08.003.
Ratova, L. G., Zykov, K. A., Dolgusheva, Ju. A., Agapova, O. Ju., Nazarov, B. M., & Chazova, I. E. (2012). Arterial'naja gipertonija i bronhoobstruktivnaja patologija-osobennosti klinicheskoj kartiny. Sistemnye gipertenzii, 9(1), 54–59. [Arterial'naya gipertoniya i bronkhoobstruktivnaya patologiya - osobennosti klinicheskoy kartiny] (in Russian). doi.org/10.26442/SG33169
Ovcharenko, S., I., Nersesyan, Z., N., & Morozova, T., E.. (2014). Chronic obstructive pulmonary disease combined with arterial hypertension: efficacy and safety ofthesustained-release indapamide (Arifon® retard) Systemic Hypertension, 11(2).54-58. doi.org/10.26442/sg29026
Triest, F. J., Studnicka, M., Franssen, F. M., Vollmer, W. M., Lamprecht, B., Wouters, E. F., ... & Vanfleteren, L. E. (2019). Airflow obstruction and cardio-metabolic comorbidities. COPD: Journal of Chronic Obstructive Pulmonary Disease, 16(2), 109-117. doi.org/10.1080/15412555.2019.1614550
Malo de Molina, R., Aguado, S., Arellano, C., Valle, M., & Ussetti, P. (2018). Ischemic heart disease during acute exacerbations of COPD. Medical Sciences, 6(4), 83. doi.org/10.3390/medsci6040083
Khassawneh, B. Y., Samrah, S. M., Jarrah, M. I., Ibdah, R. K., Ibnian, A. M., Almistarehi, A. W., ... & Khader, Y. S. (2018). Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan. International journal of chronic obstructive pulmonary disease, 13, 2759-2766. doi:10.2147/COPD.S172679 PMCID: PMC6130534.
Biscaglia, S., Ruggiero, R., Di Cesare, A., Serenelli, M., & Ferrari, R. (2019). Angina and chronic obstructive pulmonary disease: facing the perfect storm. European Heart Journal Supplements, 21(Supplement_C), 17-20. doi.org/10.1093/eurheartj/suz042
Almagro, P., De la Sierra, A., Acosta, E., Navarro, A., Garcia, M. E., Valdivieso, S., ... & Agustí, A. (2018). Spirometrically confirmed chronic obstructive pulmonary disease worsens long-term prognosis after percutaneous coronary intervention. American journal of respiratory and critical care medicine, 197(6), 824-826. doi.org/10.1164/rccm.201707-1389le
Andersson, C., Hansen, P. W., Steffensen, I. E., Andreasen, C., Weeke, P. E., Køber, L., ... & Torp-Pedersen, C. (2019). Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure–A danish nationwide registry-based study. European journal of internal medicine, 63, 56-61. doi.org/10.1016/j.ejim.2019.02.014
Bazargan, M., Smith, J. L., Robinson, P., Uyanne, J., Abdulrahoof, R., Chuku, C., & Assari, S. (2019). Chronic respiratory disease and health-related quality of life of African American older adults in an economically disadvantaged area of Los Angeles. International journal of environmental research and public health, 16(10), 1756. doi.org/10.3390/ijerph16101756
Ellingsen, J., Johansson, G., Larsson, K., Lisspers, K., Malinovschi, A., Ställberg, B., ... & Janson, C. (2020). Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD–Real-World Data from a Primary Care Setting. International journal of chronic obstructive pulmonary disease, 15, 235. doi: 10.2147/COPD.S231296.
"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.
Copyright Agreement
1. This Agreement on the transfer of rights to use the work from the Co-authors to the publisher (hereinafter the Agreement) is concluded between all the Co-authors of the work, represented by the Corresponding Author, and Kharkiv National Medical University (hereinafter the University), represented by an authorized representative of the Editorial Board of scientific journals (hereinafter the Editorial Board).
2. This Agreement is an accession agreement within the meaning of clause 1 of Article 634 of the Civil Code of Ukraine: that is, a contract, "the terms of which are established by one of the parties in forms or other standard forms, which can be concluded only by joining the other party to the proposed contract as a whole. The other party cannot offer its terms of the contract." The party that established the terms of this contract is the University.
3. If there is more than one author, the authors choose the Corresponding Author, who communicates with the Editorial Board on his own behalf and on behalf of all Co-authors regarding the publication of a written work of a scientific nature (article or review, hereinafter referred to as the Work).
4. The contract begins from the moment of submission of the manuscript of the Work by the Corresponding Author to the Editorial Board, which confirms the following:
4.1. all Co-authors of the Work are familiar with and agree with its content, at all stages of reviewing and editing the manuscript and the existence of the published Work;
4.2. all Co-authors of the Work are familiar with and agree to the terms of this Agreement.
5. The published Work is in electronic form in public access on the websites of the University and any websites and electronic databases in which the Work is posted by the University and is available to readers under the terms of the "Creative Commons" license (Attribution NonCommercial Sharealike 4.0 International)" or more free licenses "Creative Commons 4.0".
6. The Corresponding Author transfers, and the University receives, the non-exclusive property right to use the Work by placing the latter on the University's websites for the entire term of copyright. The University participates in the creation of the final version of the Work by reviewing and editing the manuscript of the article or review provided to the Editorial Board by the Corresponding Author, translating the Work into any languages. For the participation of the University in the finalization of the Work, the Co-authors agree to pay the invoice issued to them by the University, if such payment is provided by the University. The size and procedure of such payment are not the subject of this contract.
7. The University has the right to reproduce the Work or its parts in electronic and printed forms, to make copies, permanent archival storage of the Work, distribution of the Work on the Internet, repositories, scientometric databases, commercial networks, including for monetary compensation from third parties.
8. The co-authors guarantee that the manuscript of the Work does not use works whose copyright belongs to third parties.
9. The authors of the Work guarantee that at the time of submission of the manuscript of the Work to the Editorial Board, the property rights to the Work belong only to them, neither in whole nor in part have they been transferred to anyone (not alienated), they are not the subject of a lien, litigation or claims by third parties.
10. The Work may not be posted on the University's website if it violates a person's right to the privacy of his personal and family life, harms public order and health.
11. The work may be withdrawn by the Editorial Board from the University websites, libraries and electronic databases where it was placed by the Editorial Board, in cases of detection of violations of the ethics of the authors and researchers, without any compensation for the losses of the Co-authors. At the time of submission of the manuscript to the Editorial Board and all stages of its editing and review, the manuscript must not have already been published or submitted to other editorial offices.
12. The right transferred under this Agreement extends to the territory of Ukraine and foreign countries.
13. The rights of Co-authors include the requirement to indicate their names on all copies of the Work or during any public use or public mention of the Work; the requirement to preserve the integrity of the Work; legal opposition to any distortion or other encroachment on the Work, which may harm the honor and reputation of the Co-authors.
14. Co-authors have the right to control their personal non-property rights by familiarizing themselves with the text (content) and form of the Work before its publication on the University's website, when transferring it to a printing company for reproduction or when using the Work in other ways.
15. The Co-authors, in addition to the property rights not transferred under this Agreement and taking into account the non-exclusive nature of the rights transferred under this Agreement, retain the property rights to finalize the Work and to use certain parts of the Work in other works created by the Co-authors.
16. The Co-authors are obliged to notify the Editorial Board of all errors in the Work, discovered by them independently after the publication of the Work, and to take all measures to eliminate such errors as soon as possible.
17. The University undertakes to indicate the names of the Co-authors on all copies of the Work during any public use of the Work. The list of Co-authors may be shortened according to the rules for the formation of bibliographic descriptions determined by the University or third parties.
18. The University undertakes not to violate the integrity of the Work, to agree with the Corresponding Author on all changes made to the Work during processing and editing.
19. In case of violation of their obligations under this Agreement, its parties bear the responsibility defined by this Agreement and the current legislation of Ukraine. All disputes under the Agreement are resolved through negotiations, and if the negotiations do not resolve the dispute – in the courts of the city of Kharkiv.
20. The parties are not responsible for the violation of their obligations under this Agreement, if it occurred through no fault of theirs. The party is considered innocent if it proves that it has taken all measures dependent on it for the proper fulfillment of the obligation.
21. The Co-authors are responsible for the truthfulness of the facts, quotes, references to legislative and regulatory acts, other official documentation, the scientific validity of the Work, all types of responsibility to third parties who have claimed their rights to the Work. The co-authors reimburse the University for all costs caused by claims of third parties for infringement of copyright and other rights to the Work, as well as additional material costs related to the elimination of identified defects.